Author

Markus Egner

Ludwig-Maximilians-Universität München

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Aleksandar LučićiD· 1 shared Daniel MerkiD· 1 shared Elmar WolfiD· 1 shared Ewgenij ProschakiD· 1 shared Francesco GrecoiD· 1 shared Julia Schönfeld· 1 shared Kerstin HiesingeriD· 1 shared Lasse Hoffmann· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Aleksandar LučićORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Click. Screen. Degrade. A Miniaturized D2B Workflow for rapid PROTAC Discovery

M. Mitrovic, Francesco Greco, Yiliam Cruz-Garcia, Aleksandar Lučić, Lasse Hoffmann, Rohit Chander, Julia Schönfeld, Nick Liebisch, Saran Aswathaman Sivashanmugam, Martin P. Schwalm, Markus Egner, Max Lewandowski, Daniel Merk, Viktoria Morasch, Elmar Wolf, , Stefan Knapp

This paper introduces a miniaturized PROTAC synthesis workflow that bypasses compound purification, enabling rapid screening and degradation assessment of multiple targets.

Journal of Medicinal Chemistry · Jan 23, 2026Peer-reviewedBiochemistry